Customize your JAMA Network experience by selecting one or more topics from the list below.
Hwang ES, Chew T, Shiboski S, Farren G, Benz CC, Wrensch M. Risk Factors for Estrogen Receptor–Positive Breast Cancer. Arch Surg. 2005;140(1):58–62. doi:https://doi.org/10.1001/archsurg.140.1.58
Some risk factors associated with breast cancer may be more predictive of estrogen receptor (ER)− positive than ER-negative tumors.
Survey of patients enrolled in a study of breast cancer risk factors.
Community population in a northern California county.
A total of 234 individuals diagnosed as having breast cancer between July 1, 1997, and June 30, 1999, reporting Marin County, California, residence and participating in a questionnaire regarding exposure to breast cancer risk factors.
Main Outcome Measure
Diagnosis of ER-positive vs ER-negative breast cancer.
Comparison between ER-positive and ER-negative cases showed several factors predictive of ER-positive tumors. In a multivariate model, years of hormone therapy use remained the most significant predictor of ER-positive disease.
Patients diagnosed as having ER-positive breast cancer were more likely to have undergone hormone therapy. The excess of ER-positive breast cancers reported in Marin County could, therefore, in part, be related to hormone therapy.
Create a personal account or sign in to: